Merck & Co.'s Barr To Lead Clinical Development After Baynes Departs For Eikon

Longtime R&D leader Roy Baynes is leaving Merck to become chief medical officer at the biotech start-up helmed by Merck's former R&D chief Roger Perlmutter.

Merck & Co., Inc.'s longtime leader of global clinical development, chief medical officer Roy Baynes, is leaving the company to work with his former boss Roger Perlmutter at the biotech start-up Eikon Therapeutics, Inc..

Baynes will be succeeded by another executive with a long tenure at Merck. Senior VP-global clinical development Eliav Barr, who...